helicobacter-pylori

Documents about helicobacter-pylori

• High-dose Dual Therapy with Different Administration Frequencies#152450ClinicalTrials.gov
• Helicobacter pylori Infection in Tripoli, North Lebanon: Assessment and Risk Factors#195744HAL (France)
• High-level clarithromycin resistance: a metabolic vulnerability exploited by bismuth in Helicobacter pylori#241495bioRxiv / medRxiv
• Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection#238150ClinicalTrials.gov
• Linked Color Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy#803075ClinicalTrials.gov
• PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers#841027ClinicalTrials.gov
• A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients#911299ClinicalTrials.gov
• Effect of Probiotics on the Fecal Resistome During Helicobacter Pylori Eradication Therapy#67919ClinicalTrials.gov
• Empirical Rescue Therapies of Helicobacter Pylori Infection#180418ClinicalTrials.gov
• A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin#300277ClinicalTrials.gov
• Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis#329553ClinicalTrials.gov
• The Effect and Frequency of Helicobacter Pylori Infection in Primary Immune Thrombocytopenic Patients#802271ClinicalTrials.gov
• Anti-Helicobacter Pylori Antibodies (IgG) in Serum of Women With Unexplained Infertility#840112ClinicalTrials.gov
• Hp 26695 delta-cagH / Hs.746T#1056851CaltechDATA
• Supplementary file 1_Vitamin D status and Helicobacter pylori infection: clinical associations and lipid pathway differences in an exploratory metabolomics sub-study.docx#243688Figshare
• Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection#881802ClinicalTrials.gov
• Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy#201806ClinicalTrials.gov
• Helicobacter pylori regulates pro- and anti-inflammatory macrophage responses to promote bacterial survival#387650Europe PMC
• Assessing Hp Diagnosis and Treatment Quality of direct-to Consumer Telemedicine in Mainland China#827737ClinicalTrials.gov
• Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection#870395ClinicalTrials.gov
• Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity#152467ClinicalTrials.gov
• Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia#311152ClinicalTrials.gov
• Strain- and blood group-dependent binding of Helicobacter pylori to human gastric MUC5AC glycoforms.#625726Lund University Publications
• PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study#852335ClinicalTrials.gov
• Prevalance Of Helicobacter Pylori Infection In Chonic Kidney Diseased Patient Admitted To Luxor Medical Complex#979894ClinicalTrials.gov
• Efficacy Comparison of 10-Day High-Dose Versus 14-Day Standard-Dose Vonoprazan Plus Amoxicillin in Helicobacter Pylori Eradication: A Multicenter Non-Inferiority Randomized Controlled Trial#866393ClinicalTrials.gov
• Efficacy And Safety of Bismuth-Tetracycline-Rabeprazole Triple For First-Line Eradication of Helicobacter Pylori Infection#864025ClinicalTrials.gov
• Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease#18656ClinicalTrials.gov
• New Dual Therapy for Primary Treatment of Helicobacter Pylori Infection：a Pilot Study#245551ClinicalTrials.gov
• A Broad Scope of Differentials: Helicobacter pylori-Associated Chronic Gastritis Mimicking a Gastrointestinal Stromal Tumor.#342572NCBI PubMed Central
• АЛГОРИТМ ИССЛЕДОВАНИЯ БИОПТАТОВ СЛИЗИСТОЙ ОБОЛОЧКИ ЖЕЛУДКА С ЦЕЛЬЮ ОБНАРУЖЕНИЯ И ИДЕНТИФИКАЦИИ HELICOBACTER PYLORI#619364CyberLeninka
• The Association of Helicobacter Pylori in the Pathogenesis of Hyperemesis Gravidarum in Pregnant Women#856060ClinicalTrials.gov
• Functional Food Product#859218ClinicalTrials.gov
• Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway#885076ClinicalTrials.gov
• Blood Tests for Gastritis and Gastric Neoplasms#902811ClinicalTrials.gov
• Helicobacter pylori infection appears essential for stomach carcinogenesis: Observations in Semarang, Indonesia#1015485Diponegoro University | Institutional Repository (UNDIP-IR)
• Observational Study of the Association Between Oral Helicobacter pylori, Fixed Orthodontic Appliances, and Gastric Cancer Risk.#12775NCBI PubMed Central
• The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori#217057ClinicalTrials.gov
• Helicobacter pylori infection among the Dayak community in Kuching Division, Sarawak: findings from a community-based study.#235980NCBI PubMed Central
• N-methyl d-Aspartate Channels Link Ammonia and Epithelial Cell Death Mechanisms in Helicobacter pylori Infection#392244MIT Open Scholarship
• Helicobacter pylori infection in children: an overview of global characteristics and the effectiveness of tailored therapy.#415384NCBI PubMed Central
• Anti-urease therapy: a targeted approach to mitigating antibiotic resistance in Helicobacter pylori while preserving the gut microflora#254199HAL (France)
• ОТВЕТ CD4+ Т-КЛЕТОК НА ПРЕЗЕНТАЦИЮ АНТИГЕНОВ HELICOBACTER PYLORI В УСЛОВИЯХ IN VITRO У ПАЦИЕНТОВ С H. PYLORI-ИНФЕКЦИЕЙ И ГАСТРИТОМ С ЭРОЗИЕЙ СЛИЗИСТОЙ ЖЕЛУДКА И БЕЗ НЕЕ#619396CyberLeninka
• Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection#238142ClinicalTrials.gov
• Bile acid metabolism dysregulation following Helicobacter pylori eradication promotes plasmid-mediated antimicrobial resistance in the gut microbiome.#285125NCBI PubMed Central
• Unveiling a missing component of the atypical type IV secretion system required for natural transformation of Helicobacter pylori.#396014NCBI PubMed Central
• Диагностическая значимость взаимодействия Candida albicans и Helicobacter pylori в оценке полноты достижения целей эрадикационной терапии#623689CyberLeninka
• Proton Pump Inhibitor Treatment Stop#903998ClinicalTrials.gov
• Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection#879685ClinicalTrials.gov
• Vonoprazan–Amoxicillin Dual Therapy with or Without Saccharomyces boulardii Supplementation as a Rescue Regimen for Helicobacter pylori Infection.#4121NCBI PubMed Central